111, Inc. Sponsored ADR

YI Healthcare Medical Distribution

111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.

3.09 0.00 0.00%
Market cap
$16.0M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
3.31
Beneish M
−3.28
Dividend safety
n/a
Older periods Jun '25 Sep '25 Dec '25 Mar '26
Piotroski F-Score

+8 more TTM periods

7 5 5 4
ROE
11.19% 10.10% 9.82% 12.26%
ROA
(2.80%) (2.45%) (2.73%) (3.89%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(24.98%) (36.78%) (34.53%) (52.06%)
Average Days of Receivables
6.94 7.78 7.55 6.05
Free Cash Flow per Share
1.78 0.48 1.02 (1.34)
Free Cash Flow
15.42 4.17 8.84 (11.78)
Capital Expenditures
— — (8.20) —
Other line items
Cash ROIC
(1,355.36%) 127.92% 79.76% 77.70%
Accounts Receivable Turnover
41.58 37.06 38.31 51.50
Accounts Payable Turnover
8.42 7.15 8.07 7.64
Inventory Turnover
10.03 8.88 10.17 9.37
Average Days of Payables
43.09 45.38 39.56 41.22
Days of Inventory on Hand
35.43 36.71 30.80 34.55
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.52% 2.53% 2.61% 2.74%
Share Based Compensation of Revenue
0.00% 0.00% 3.32% 0.00%
Interest Coverage
(0.16) (0.32) (0.07) (0.65)
Operating CF/Net income
(1.51) (0.44) (1.79) 0.95
Depreciation/Fixed assets
0.00 0.00 4.31 0.00
Capex/Depreciation
— — (0.63) —
Revenue per Share
224.33 212.99 206.35 187.78
Operating CF per Share
1.78 0.48 1.96 (1.34)
Capex per Share
0.00 0.00 (0.94) 0.00
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates